JOHNSON & JOHNSON
•CIK: 200406•Filing: Q4 2025
**JOHNSON & JOHNSON** A $555M fund managing 17 positions, this strategy exhibits concentrated exposure to healthcare and related sectors. The portfolio is significantly anchored by PTGX at $213.9M and NBTX at $130.0M, representing substantial conviction in these names. Further notable allocations include RAPP ($54.1M) and BEN ($52.8M), suggesting a targeted, deep-value approach within the life sciences space.
Total AUM
$554.6M
QoQ Performance
+10.1%
Positions
17
Top 10 Concentration
98.4%
Latest Filing
Q4 2025
Top Holdings Allocation
PTGX
NBTX
RAPP
Meir
CVRX
PTGX38.6%
NBTX23.4%
RAPP9.8%
MeiraGTx9.5%
CVRX5.2%
CTNM4.1%
LEGN3.2%
XNCR2.1%
📈 Biggest Buys
ACET
Adicet Bio, Inc.
NEW
0.0% of portfolio
📉 Biggest Sells
CVRX
CVRx, Inc.
-1.9%
5.2% of portfolio
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q3 2025
Changes from Q3 2025
NEW1 new position
↓1 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023